Novasep
Site Eiffel, 82 boulevard de la Moselle
BP 50
Pompey
54340
France
Tel: 33-3-83-49-71-30
Fax: 33-3-83-49-71-49
Email: novasep@novasep.com
80 articles about Novasep
-
Sartorius Stedim Biotech completes acquisition of Novasep's chromatography division
2/8/2022
Sartorius Stedim Biotech, a leading partner of the biopharma industry, announced that it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission.
-
Sartorius completes acquisition of Novasep's chromatography division
2/8/2022
The life science group Sartorius announced that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission.
-
Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.
-
Thermo Fisher Scientific announced the completion of Henogen SA, Groupe Novasep SAS’s viral vector manufacturing business in Belgium. The deal was for €725 million in cash.
-
BioSpace Global Roundup: Ayala Moves Forward with Desmoid Tumor Asset in Phase II/III Study
1/7/2021
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business. -
Sartorius to acquire Novasep's chromatography process equipment division
1/6/2021
The life science company Sartorius announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.
-
Sartorius Stedim Biotech to acquire Novasep's chromatography process equipment division
1/6/2021
Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, announced it has entered into an agreement to acquire the chromatography process equipment division of Novasep.
-
BioSpace Global Roundup, Nov. 5
11/5/2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
BioSpace Global Roundup, May 28
5/28/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses. -
NOVASEP and LYSOGENE Announce Their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Product
5/26/2020
Novasep announced the signature of an agreement for the development and manufacturing of LYS-GM101, an AAVrh10-based gene therapy drug candidate for the treatment of GM1 Gangliosidosis, a rare neuronopathic lysosomal storage disorder.
-
BioSpace Global Roundup, March 5
3/5/2020
Life sciences companies from across the globe provide updates on their businesses and pipelines. -
Novasep Launches oXYgene™, a Fully Integrated Offer for Boosting Viral Vector Production
12/3/2019
Leveraging on its recent investments Senrise-IV and Senefill, Novasep launches a unique 2-year turnkey plant offer to accelerate commercial production of viral vectors.
-
Senefill, Novasep's Commercial Facility for Aseptic Filling and Finishing Operations, Is Now Ready to Operate
10/1/2019
Senefill will be commissioned on October 1, 2019 and will offer Fill & Finish clinical and commercial services for biological products, from formulation to packaging
-
NOVASEP and THERAVECTYS Enter Into a New License Agreement on DNA Flap Technology for GMP Manufacturing of Lentiviral Vectors
4/18/2019
Novasep, today announced the signing of a license agreement allowing Novasep to use Institut Pasteur's DNA Flap Technology to produce GMP-grade lentiviral vectors for clinical use in all therapeutic applications including gene therapy, cell therapy, immunotherapy and vaccination, for any customer, worldwide
-
Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography
3/5/2019
This company is a recognized system provider with substantial expertise in the design, manufacture and control of resin-based batch and continuous chromatography systems.
-
Enzene Biosciences Chooses Novasep BioSC® Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb
2/5/2019
Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC® Pilot for purification of biopharmaceuticals to operate in its Pune plant.
-
Novasep Industrializes Potato Protein Purification Unit for Solanic B.V.
10/22/2018
This represents a step forward for the plant-based protein purification industry, with the first compact bed chromatography system for the purification of vegetable proteins
-
Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s
8/27/2018
Novasep is proud to announce that its API development and manufacturing site in Chasse-sur-Rhone, France, has been successfully inspected by the US Food and Drug Administration (FDA)
-
Novasep Launches BioSC® Pilot, Breakthrough Chromatography and DSP Skid for Biologics Purification
6/11/2018
BioSC® Pilot is a new tool for continuous and intensified downstream processes in the biopharmaceutical industry.
-
Novasep Invests €10M in "SeneFill", Its New Facility for Commercial Aseptic Fill & Finish Operations
5/3/2018
Novasep announces a EUR10M investment in a commercial fill & finish facility for viral vectors, mAbs and other low-volume biologics.